Investor Rights Agreements in the Biotechnology Industry

425 Contracts & Agreements

Browse by Company

4D Molecular Therapeutics Inc (3 contracts)
89bio, Inc. (1)
ABEONA THERAPEUTICS INC. (3)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (1)
Actinium Pharmaceuticals, Inc. (3)
Acumen Pharmaceuticals, Inc. (1)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (1)
Adamas Pharmaceuticals Inc (1)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (1)
Adverum Biotechnologies, Inc. (2)
Aeglea BioTherapeutics, Inc. (2)
Aerovate Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (1)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (2)
Akebia Therapeutics, Inc. (5)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (1)
Aldeyra Therapeutics, Inc. (2)
Aligos Therapeutics, Inc. (1)
Allakos Inc. (2)
Allena Pharmaceuticals, Inc. (1)
Allogene Therapeutics, Inc. (1)
Allovir, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (2)
ALPINE IMMUNE SCIENCES, INC. (1)
ALX ONCOLOGY HOLDINGS INC (1)
AMICUS THERAPEUTICS, INC. (2)
AmpliPhi Biosciences Corp (4)
ANAPTYSBIO INC (2)
Annexon, Inc. (1)
Apellis Pharmaceuticals, Inc. (2)
APPLIED GENETIC TECHNOLOGIES CORP (1)
Applied Molecular Transport Inc. (1)
Applied Therapeutics Inc. (1)
Aptinyx Inc. (1)
Aptose Biosciences Inc. (1)
Aravive, Inc. (1)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (2)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (1)
ARROWHEAD PHARMACEUTICALS, INC. (4)
Arsanis, Inc. (2)
Artiva Biotherapeutics, Inc. (1)
ASSEMBLY BIOSCIENCES, INC. (1)
Atara Biotherapeutics, Inc. (1)
ATHERSYS, INC (2)
Atreca, Inc. (1)
Aura Biosciences, Inc. (1)
AVEO PHARMACEUTICALS INC (1)
AVROBIO, Inc. (1)
Axcella Health Inc. (1)
Ayala Pharmaceuticals, Inc. (3)
AZIYO BIOLOGICS, INC. (1)
Beam Therapeutics Inc. (1)
BeiGene, Ltd. (2)
BELLICUM PHARMACEUTICALS, INC (2)
BioAtla, Inc. (1)
BioCardia, Inc. (1)
BIOCEPT INC (1)
Biogen Inc. (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
Biomea Fusion, Inc. (1)
Black Diamond Therapeutics, Inc. (1)
bluebird bio, Inc. (1)
Blueprint Medicines Corp (1)
Bolt Biotherapeutics, Inc. (1)
Cabaletta Bio, Inc. (1)
Calithera Biosciences, Inc. (1)
CANCER GENETICS, INC (2)
Candel Therapeutics, Inc. (1)
CareDx, Inc. (2)
Caribou Biosciences, Inc. (1)
CASTLE BIOSCIENCES INC (2)
Castle Creek Biosciences, Inc. (1)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (2)
Century Therapeutics, Inc. (1)
Checkmate Pharmaceuticals, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (2)
Cidara Therapeutics, Inc. (1)
Codiak BioSciences, Inc. (2)
CohBar, Inc. (1)
Coherus BioSciences, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
Corvus Pharmaceuticals, Inc. (1)
Crinetics Pharmaceuticals, Inc. (1)
Cullinan Oncology, LLC (1)
Cyclacel Pharmaceuticals, Inc. (2)
CytomX Therapeutics, Inc. (1)
Day One Biopharmaceuticals Holding Co LLC (1)
Decibel Therapeutics, Inc. (1)
DECIPHER BIOSCIENCES, INC. (1)
Deciphera Pharmaceuticals, Inc. (1)
Denali Therapeutics Inc. (1)
Dermira, Inc. (1)
Design Therapeutics, Inc. (1)
DiaMedica Therapeutics Inc. (1)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (1)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (1)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Elevation Oncology, Inc. (1)
Eliem Therapeutics, Inc. (1)
Entasis Therapeutics Holdings Inc. (3)
Entrada Therapeutics, Inc. (1)
Environmental Impact Acquisition Corp (1)
Epizyme, Inc. (1)
Esperion Therapeutics, Inc. (2)
Evelo Biosciences, Inc. (2)
EXICURE, INC. (1)
FATE THERAPEUTICS INC (2)
FIBROGEN INC (3)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (1)
Flexion Therapeutics Inc (1)
Foghorn Therapeutics Inc. (3)
Forma Therapeutics Holdings, Inc., (1)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (1)
Galecto Inc. (2)
Galera Therapeutics, Inc. (2)
Gemphire Therapeutics Inc. (2)
GENELUX CORP (1)
Generation Bio Co. (1)
GENEREX BIOTECHNOLOGY CORP (1)
Global Blood Therapeutics, Inc. (2)
GLYCOMIMETICS INC (1)
Gossamer Bio, Inc. (1)
Grail, Inc. (1)
Graphite Bio, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (3)
GX Acquisition Corp. (2)
Harpoon Therapeutics, Inc. (1)
HEAT BIOLOGICS, INC. (1)
HISTOGENICS CORP (1)
Homology Medicines, Inc. (2)
iBio, Inc. (1)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (1)
IGM Biosciences, Inc. (1)
Imago BioSciences, Inc. (1)
Immuneering Corp (2)
IMPEL NEUROPHARMA INC (1)
IN8BIO, INC. (1)
Inhibrx, Inc. (2)
Inozyme Pharma, Inc. (2)
Instil Bio, Inc. (1)
Intellia Therapeutics, Inc. (3)
International Stem Cell CORP (3)
INTREXON CORP (1)
Invitae Corp (1)
IONIS PHARMACEUTICALS INC (1)
IRONWOOD PHARMACEUTICALS INC (1)
Janux Therapeutics, Inc. (2)
Karuna Therapeutics, Inc. (1)
Karyopharm Therapeutics Inc. (1)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (3)
Kinnate Biopharma Inc. (1)
Kiromic Biopharma, Inc. (1)
Kodiak Sciences Inc. (2)
Krystal Biotech, Inc. (1)
Kymera Therapeutics, Inc. (1)
Lantern Pharma Inc. (1)
LEXICON PHARMACEUTICALS, INC. (1)
LogicBio Therapeutics, Inc. (1)
Lyell Immunopharma, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (1)
MEDICINOVA INC (1)
Medovex Corp. (1)
MERRIMACK PHARMACEUTICALS INC (2)
Mersana Therapeutics, Inc. (1)
Metacrine, Inc. (1)
Minerva Neurosciences, Inc. (2)
Mirum Pharmaceuticals, Inc. (1)
Moderna, Inc. (1)
Molecular Templates, Inc. (1)
Momenta Pharmaceuticals, Inc. (1)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (2)
Myovant Sciences Ltd. (2)
Natera, Inc. (1)
NEUROTROPE BIOSCIENCE, INC. (1)
NEWLINK GENETICS CORP (1)
NexImmune, Inc. (1)
NextCure, Inc. (1)
Nkarta, Inc. (1)
NOVAVAX INC (1)
Novus Therapeutics, Inc. (1)
Nurix Therapeutics, Inc. (1)
Nuvalent, Inc. (1)
Olema Pharmaceuticals, Inc. (1)
Omega Therapeutics, Inc. (1)
Oncorus, Inc. (1)
OPGEN INC (1)
Ophthotech Corp. (1)
ORGANOVO HOLDINGS, INC. (1)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (9)
Ovid Therapeutics Inc. (1)
Oyster Point Pharma, Inc. (1)
Passage BIO, Inc. (1)
PepGen Inc. (1)
Pfenex Inc. (2)
PhaseBio Pharmaceuticals Inc (1)
PMV Pharmaceuticals, Inc. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (2)
Praxis Precision Medicines, Inc. (1)
Prelude Therapeutics Inc (1)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (1)
PROGENITY, INC. (7)
Prometheus Biosciences, Inc. (1)
Protagonist Therapeutics, Inc (2)
PROTEON THERAPEUTICS INC (2)
PTC THERAPEUTICS, INC. (2)
Pyxis Oncology, Inc. (1)
RAPT Therapeutics, Inc. (1)
RECURSION PHARMACEUTICALS, INC. (1)
REGENXBIO Inc. (1)
Regulus Therapeutics Inc. (5)
Relay Therapeutics, Inc. (2)
Reneo Pharmaceuticals, Inc. (1)
RenovoRx, Inc. (1)
Revolution Medicines, Inc. (1)
RHYTHM PHARMACEUTICALS, INC. (2)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (5)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (1)
Sana Biotechnology, Inc. (1)
SEATTLE GENETICS INC (1)
SELECTA BIOSCIENCES INC (1)
Sensei Biotherapeutics, Inc. (2)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (1)
Sesen Bio, Inc. (1)
Shattuck Labs, Inc. (1)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (1)
SOLENO THERAPEUTICS INC (1)
Spectrum Pharmaceuticals, Inc. (3)
Spero Therapeutics, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (3)
Stellar Biotechnologies, Inc. (1)
Stoke Therapeutics, Inc. (1)
SUNESIS PHARMACEUTICALS INC (2)
Surface Oncology, Inc. (1)
SUTRO BIOPHARMA, INC. (1)
Syndax Pharmaceuticals Inc (2)
SYNLOGIC, INC. (2)
T2 Biosystems, Inc. (2)
Talaris Therapeutics, Inc. (1)
Taysha Gene Therapies, Inc. (1)
TCR2 THERAPEUTICS INC. (1)
Tenaya Therapeutics, Inc. (1)
Tracon Pharmaceuticals, Inc. (1)
TREVENA INC (1)
TScan Therapeutics, Inc. (1)
Turning Point Therapeutics, Inc. (1)
Tyra Biosciences, Inc. (2)
Ultragenyx Pharmaceutical Inc. (1)
Unity Biotechnology, Inc. (1)
Unum Therapeutics Inc. (1)
VACCINEX, INC. (1)
Vaxcyte, Inc. (1)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (2)
Verastem, Inc. (1)
Verve Therapeutics, Inc. (1)
Viela Bio, Inc. (1)
Vigil Neuroscience, Inc. (1)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (1)
VITAL THERAPIES INC (3)
Vor Biopharma Inc. (1)
Voyager Therapeutics, Inc. (1)
vTv Therapeutics Inc. (2)
Werewolf Therapeutics, Inc. (1)
Xencor Inc (1)
Xenon Pharmaceuticals Inc. (1)
ZAFGEN, INC. (3)
Zentalis Pharmaceuticals, LLC (1)

Recent Contracts

Investor Rights Agreement dated as of January 12, 2024, between Celularity Inc. and Resorts World Inc Pte Ltd (GX Acquisition Corp., Filed With SEC on January 17, 2024)
Investor Rights Agreement, between Celularity Inc. and Dragasac Limited, dated as of January 12, 2024 (GX Acquisition Corp., Filed With SEC on January 17, 2024)
Investor Rights Agreement, dated October 31, 2023, by and between Synaptogenix, Inc., Cannasoul Analytics Ltd. and other investors party thereto (NEUROTROPE BIOSCIENCE, INC., Filed With SEC on November 6, 2023)
Investor Rights Agreement, dated October 15, 2023 by and between the Company and Gilead Sciences, Inc (ASSEMBLY BIOSCIENCES, INC., Filed With SEC on October 17, 2023)
Amendment No. 4 to Fourth Amended and Restated Investors Rights Agreement, dated as of September 18, 2023, by and among Biora Therapeutics, Inc., and certain of its stockholders (PROGENITY, INC., Filed With SEC on September 19, 2023)
Investor Rights Agreement (Aptose Biosciences Inc., Filed With SEC on September 12, 2023)
Amendment No. 1 to Investor Rights Agreement, dated October 11, 2022 (Arcus Biosciences, Inc., Filed With SEC on October 11, 2022)
Investor Rights Agreement, by and between Dong-A ST Co. Ltd. and the Company, dated September 14, 2022 (Gemphire Therapeutics Inc., Filed With SEC on September 14, 2022)
Amended and Restated Investors Rights Agreement, among Disc Medicine, Inc. and certain of its stockholders, dated August 23, 2021 (FS Development Corp., Filed With SEC on September 2, 2022)
Amendment No. 2 to Amended and Restated Investors Rights Agreement, dated as of June 4, 2021 (Ayala Pharmaceuticals, Inc., Filed With SEC on August 15, 2022)
Investors Rights Agreement, by and among the registrant and AbbVie, Inc. and Aladar Szalay, Ph.D., dated January 2010 (GENELUX CORP, Filed With SEC on June 24, 2022)
Investor Rights and Lock-up Agreement (Dynamics Special Purpose Corp., Filed With SEC on June 15, 2022)
Amendment No. 1 to Investor Rights Agreement, dated as of May 23, 2022, by and between the Company and Parent (Entasis Therapeutics Holdings Inc., Filed With SEC on May 23, 2022)
Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments (Outlook Therapeutics, Inc., Filed With SEC on April 22, 2022)
Amended and Restated Investors Rights Agreement, dated July 30, 2021, among the Registrant and certain of its stockholders (PepGen Inc., Filed With SEC on April 15, 2022)
Amended and Restated Investors Rights Agreement by and among Senti Biosciences, Inc. and certain of its stockholders, dated October 22, 2020 (Dynamics Special Purpose Corp., Filed With SEC on February 14, 2022)
Second Amended and Restated Investors Rights Agreement, dated February 9, 2022, by and among the Company, Innoviva, Inc. and Innoviva (AmpliPhi Biosciences Corp, Filed With SEC on February 11, 2022)
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated March 26, 2021 (Arcellx, Inc., Filed With SEC on January 14, 2022)
Amendment to Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 10, 2021 (Foghorn Therapeutics Inc., Filed With SEC on December 13, 2021)
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of August 13, 2021 (Vigil Neuroscience, Inc., Filed With SEC on November 19, 2021)
Amended and Restated Investor Rights Agreement, dated as of April 18, 2018 (RenovoRx, Inc., Filed With SEC on November 15, 2021)
Amendment to Investor Rights Agreement, by and between Athersys, Inc. and HEALIOS K.K., dated as of August 5, 2021 (ATHERSYS, INC, Filed With SEC on November 15, 2021)
Amendment No. 1 to Amended and Restated Investors Rights Agreement, dated January 25, 2021 (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on November 2, 2021)
Amended and Restated Investors Rights Agreement among the Registrant and certain of (Entrada Therapeutics, Inc., Filed With SEC on October 8, 2021)
Fifth Amended and Restated Investors Rights Agreement (Aura Biosciences, Inc., Filed With SEC on October 8, 2021)
Amended and Restated Investor Rights Agreement, dated March 5, 2021 (Pyxis Oncology, Inc., Filed With SEC on October 1, 2021)
Amended and Restated Investors Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders, as amended (Tyra Biosciences, Inc., Filed With SEC on September 9, 2021)
Second Amended and Restated Investor Rights Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (iBio, Inc., Filed With SEC on August 27, 2021)
Amended and Restated Investors Rights Agreement, dated March 5, 2021, by and among the Registrant and certain of its stockholders (Tyra Biosciences, Inc., Filed With SEC on August 20, 2021)
Investor Rights Agreement, dated as of August 11, 2021, by and among Surrozen, Inc., Consonance Life Sciences, and certain other investors (Consonance-HFW Acquisition Corp., Filed With SEC on August 17, 2021)
Amendment No. 3 to Fourth Amended and Restated Investors Rights Agreement, dated as of May 31, 2021, by and among Progenity, Inc., and certain of its stockholders (PROGENITY, INC., Filed With SEC on August 12, 2021)
Investor Rights Agreement, dated as of August 9, 2021, by and among Environmental Impact Acquisition Corp. and the other parties identified as a Holder on the signature pages... (Environmental Impact Acquisition Corp, Filed With SEC on August 10, 2021)
Amended and Restated Investors Rights Agreement, as amended, dated December 21, 2020, byand among the Registrant and the other parties thereto (Immuneering Corp, Filed With SEC on July 26, 2021)
Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated April 16, 2021 (Adagio Therapeutics, Inc., Filed With SEC on July 16, 2021)
Amended and Restated Investor Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto (Eliem Therapeutics, Inc., Filed With SEC on July 16, 2021)
Amended and Restated Investors Rights Agreement, dated December 9, 2019, by and among the Registrant and the other parties thereto (Castle Creek Biosciences, Inc., Filed With SEC on July 16, 2021)
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 17, 2020 (Tenaya Therapeutics, Inc., Filed With SEC on July 9, 2021)
Amended and Restated Investors Rights Agreement, dated March 4, 2021 (Omega Therapeutics, Inc., Filed With SEC on July 9, 2021)
Amended and Restated Investors Rights Agreement, dated December 21, 2020, by and among the Registrant and the other parties thereto (Immuneering Corp, Filed With SEC on July 9, 2021)
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of April 30, 2021 (Nuvalent, Inc., Filed With SEC on July 7, 2021)